Quinolinic Acid in Neurological Disease: Opportunities for Novel Drug Discovery
- 1 January 1994
- book chapter
- Published by Elsevier
- Vol. 30, 85-127
- https://doi.org/10.1016/s1054-3589(08)60173-8
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in ratsNeuroscience Letters, 1990
- Molecular cloning, sequencing and expression of human interferon-γ-inducible indoleamine 2,3-dioxygenase cDNABiochemical and Biophysical Research Communications, 1990
- Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal systemNeuroscience Letters, 1989
- Cofactor activity of dihydroflavin mononucleotide and tetrahydrobiopterin for murine epididymal indoleamine 2,3-dioxygenaseBiochemical and Biophysical Research Communications, 1986
- Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acidNeuroscience Letters, 1984
- The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging processNeuroscience Letters, 1984
- Differential vulnerability of central neurons of the rat to quinolinic acidNeuroscience Letters, 1983
- Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNSEuropean Journal of Pharmacology, 1981
- Biosynthesis of NAD and nicotinic acid by Clostridium butylicumBiochemical and Biophysical Research Communications, 1966